Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03235180 · ClinicalTrials.gov registry record · Phase 4
Ultrasound Evaluation of Crohn's Disease
A Phase 4 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT03235180: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.
NCT03235180 is a Phase 4 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03235180, a Phase 4 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.
Primary Outcome
Shear wave speed is a measure of small bowel stiffness; this will be measured on the General Electric (GE) Logiq E9 Ultrasound Scanner.
Interventions
- DRUG Sulfur Hexafluoride
- DEVICE Ultrasound Elastography
- DEVICE Ultrasound Vascularity
- DEVICE Magnetic Resonance Enterography (MRE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2021-10-12 |
| Phase | Phase 4 |
Why NCT03235180 stopped before completion
NCT03235180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Sulfur Hexafluoride is the first listed.
NCT03235180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03235180 about?
NCT03235180 is a clinical study titled "Ultrasound Evaluation of Crohn's Disease". The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.
What is the current status of trial NCT03235180?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2017-06-16. Estimated completion is 2021-10-12.
What interventions are being tested in trial NCT03235180?
The interventions under investigation include: Sulfur Hexafluoride (DRUG), Ultrasound Elastography (DEVICE), Ultrasound Vascularity (DEVICE), Magnetic Resonance Enterography (MRE) (DEVICE).
Who is sponsoring clinical trial NCT03235180?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03235180's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI